Intralesional interferon alfa for treatment of recurrent lentigo maligna of the eyelid in a patient with primary acquired melanosis

Arch Dermatol. 2000 Nov;136(11):1415-6. doi: 10.1001/archderm.136.11.1415.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Eyelid Neoplasms / complications
  • Eyelid Neoplasms / drug therapy*
  • Humans
  • Hutchinson's Melanotic Freckle / complications
  • Hutchinson's Melanotic Freckle / drug therapy*
  • Injections, Intralesional
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / therapeutic use*
  • Male
  • Melanosis / complications*
  • Middle Aged
  • Neoplasm Recurrence, Local / complications
  • Neoplasm Recurrence, Local / drug therapy*

Substances

  • Antineoplastic Agents
  • Interferon-alpha